US Stock MarketDetailed Quotes

NVS Novartis AG

Watchlist
  • 103.060
  • -0.340-0.33%
Close Nov 15 16:00 ET
  • 103.000
  • -0.060-0.06%
Post 19:34 ET
206.04BMarket Cap12.10P/E (TTM)

Novartis AG Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
18.51%6.29B
38.61%4.88B
-20.58%2.27B
9.06%14.22B
-32.40%2.55B
24.07%5.3B
-5.58%3.52B
72.95%2.85B
-2.44%13.04B
73.00%3.77B
Net income from continuing operations
110.51%3.19B
42.93%3.25B
25.02%2.69B
41.71%8.57B
100.61%2.64B
13.76%1.51B
33.98%2.27B
-3.11%2.15B
-73.59%6.05B
-91.34%1.32B
Operating gains losses
-156.45%-159M
-15.91%74M
132.89%99M
43.77%-167M
186.29%107M
-520.00%-62M
161.11%88M
-296.05%-301M
98.14%-297M
99.15%-124M
Depreciation and amortization
-36.84%1.97B
-31.97%1.16B
-29.73%1.31B
23.45%8.28B
-12.84%1.59B
62.45%3.11B
-5.22%1.71B
33.10%1.87B
19.80%6.71B
81.66%1.82B
Deferred tax
412.82%200M
47.64%595M
19.19%441M
-51.15%551M
-202.76%-261M
-84.82%39M
16.14%403M
-17.78%370M
-30.58%1.13B
68.21%254M
Other non cash items
182.00%41M
-71.54%-223M
65.18%-180M
-26,066.67%-785M
53.23%-87M
-134.01%-50M
-402.33%-130M
-10,240.00%-517M
98.56%-3M
-745.45%-186M
Change In working capital
-11.71%1.04B
332.73%238M
-63.30%-1.99B
53.64%-369M
-184.21%-384M
163.53%1.18B
201.85%55M
39.43%-1.22B
-990.41%-796M
-47.10%456M
-Change in receivables
380.34%328M
-12.08%-501M
-31.43%-920M
-278.84%-1.5B
-156.07%-240M
13.97%-117M
-8.23%-447M
-41.13%-700M
-12.78%-397M
100.94%428M
-Change in inventory
372.73%90M
90.27%-18M
64.54%-128M
2.50%-546M
171.74%33M
74.42%-33M
4.64%-185M
15.06%-361M
-449.02%-560M
-155.56%-46M
-Change in payables and accrued expense
40.76%-109M
-294.52%-142M
-1,673.08%-409M
364.64%479M
291.67%564M
-52.07%-184M
563.64%73M
118.18%26M
-63.06%-181M
-68.83%144M
-Change in other current assets
-425.00%-52M
-1,266.67%-105M
-149.54%-272M
-48.81%-125M
-2,150.00%-41M
-87.40%16M
-87.14%9M
69.97%-109M
53.07%-84M
-99.27%2M
-Change in other current liabilities
-47.66%783M
65.95%1B
-251.35%-260M
211.50%1.33B
-872.22%-700M
111.90%1.5B
28.18%605M
87.33%-74M
-36.51%426M
-4.35%-72M
Cash from discontinued investing activities
-80.12%238M
0
-83.41%74M
59M
105M
-29.84%1.2B
343M
Operating cash flow
16.88%6.29B
36.33%4.88B
-23.40%2.27B
1.56%14.46B
-38.04%2.55B
13.92%5.38B
-4.77%3.58B
79.32%2.96B
-5.54%14.24B
5.84%4.11B
Investing cash flow
Cash flow from continuing investing activities
81.34%-374M
-234.06%-3.21B
-108.40%-899M
252.89%6.72B
22.52%-1.02B
-137.75%-2B
91.74%-960M
14.31%10.71B
-61.12%1.9B
-125.11%-1.32B
Net PPE purchase and sale
-52.38%-320M
-0.90%-223M
-50.67%-226M
-8.58%-823M
-18.63%-242M
-4.48%-210M
9.43%-221M
33.04%-150M
11.35%-758M
-98.06%-204M
Net intangibles purchase and sale
-132.48%-455M
33.43%-448M
-920.88%-929M
122.72%262M
-95.31%-375M
664.92%1.4B
-238.19%-673M
83.02%-91M
-43.41%-1.15B
51.02%-192M
Net business purchase and sale
98.17%-63M
-3,773.26%-3.33B
-911.54%-263M
-313.08%-3.57B
-22.22%-11M
-57,533.33%-3.45B
-40.98%-86M
96.90%-26M
-104.22%-864M
-100.04%-9M
Net investment purchase and sale
84.46%463M
3,875.00%795M
-95.27%519M
131.82%10.85B
56.89%-394M
-95.64%251M
100.18%20M
0.07%10.97B
133.78%4.68B
93.88%-914M
Net other investing changes
--1M
----
----
----
----
----
----
----
98.18%-1M
--0
Cash from discontinued investing activities
Investing cash flow
83.09%-374M
-204.56%-3.21B
-108.46%-899M
281.20%5.6B
-19.97%-1.76B
-142.55%-2.21B
90.94%-1.05B
13.41%10.62B
-65.11%1.47B
-132.15%-1.47B
Financing cash flow
Cash flow from continuing financing activities
91.13%-382M
15.03%-3.2B
42.60%-5.16B
15.07%-17.56B
87.90%-496M
9.33%-4.31B
-63.60%-3.77B
5.58%-9B
-26.96%-20.68B
-25.08%-4.1B
Net issuance payments of debt
192.83%2.51B
207.62%833M
23.58%1.15B
25.15%-1.94B
148.41%610M
-31.07%-2.7B
-333.84%-774M
130.94%933M
56.82%-2.59B
59.50%-1.26B
Net common stock issuance
-75.63%-2.85B
45.35%-1.62B
61.92%-1.1B
18.15%-8.72B
53.29%-1.25B
40.21%-1.63B
-8.95%-2.96B
-13.53%-2.89B
-248.45%-10.65B
-1,709.46%-2.68B
Cash dividends paid
----
---2.42B
28.23%-5.21B
3.34%-7.26B
--0
----
----
3.34%-7.26B
-1.87%-7.51B
--0
Proceeds from stock option exercised by employees
--5M
--25M
----
53.00%153M
---5M
----
----
69.15%159M
88.68%100M
--0
Net other financing activities
-286.96%-43M
28.57%-25M
-120.75%-11M
605.26%192M
193.17%150M
-28.13%23M
-146.67%-35M
140.91%53M
-155.07%-38M
-794.44%-161M
Cash from discontinued financing activities
2,661.34%3.29B
-205.71%-111M
31,481.82%3.47B
129M
-206M
357.69%119M
105M
Financing cash flow
54.09%-382M
12.02%-3.2B
43.88%-5.16B
30.56%-14.28B
84.80%-607M
82.44%-832M
-57.99%-3.64B
3.42%-9.2B
-26.43%-20.56B
-22.85%-3.99B
Net cash flow
Beginning cash position
-27.40%7.9B
-21.09%9.47B
78.17%13.39B
-39.41%7.52B
42.16%12.41B
200.28%10.89B
-13.37%12B
-39.41%7.52B
28.46%12.41B
21.01%8.73B
Current changes in cash
228.00%5.53B
-37.52%-1.53B
-186.79%-3.8B
218.90%5.78B
161.33%828M
-67.46%1.69B
89.05%-1.11B
194.48%4.38B
-261.13%-4.86B
-125.98%-1.35B
Effect of exchange rate changes
206.02%176M
-3,300.00%-34M
-217.76%-126M
412.50%100M
13.48%160M
-107.50%-166M
98.08%-1M
360.98%107M
87.97%-32M
--141M
End cash Position
9.71%13.61B
-27.40%7.9B
-21.09%9.47B
78.17%13.39B
78.17%13.39B
42.16%12.41B
200.28%10.89B
-13.37%12B
-39.41%7.52B
-39.41%7.52B
Free cash flow
16.87%5.49B
54.85%4.15B
-56.81%1.11B
-2.43%11.71B
-51.18%1.76B
10.50%4.7B
-15.57%2.68B
225.06%2.57B
-4.14%12B
8.76%3.61B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 18.51%6.29B38.61%4.88B-20.58%2.27B9.06%14.22B-32.40%2.55B24.07%5.3B-5.58%3.52B72.95%2.85B-2.44%13.04B73.00%3.77B
Net income from continuing operations 110.51%3.19B42.93%3.25B25.02%2.69B41.71%8.57B100.61%2.64B13.76%1.51B33.98%2.27B-3.11%2.15B-73.59%6.05B-91.34%1.32B
Operating gains losses -156.45%-159M-15.91%74M132.89%99M43.77%-167M186.29%107M-520.00%-62M161.11%88M-296.05%-301M98.14%-297M99.15%-124M
Depreciation and amortization -36.84%1.97B-31.97%1.16B-29.73%1.31B23.45%8.28B-12.84%1.59B62.45%3.11B-5.22%1.71B33.10%1.87B19.80%6.71B81.66%1.82B
Deferred tax 412.82%200M47.64%595M19.19%441M-51.15%551M-202.76%-261M-84.82%39M16.14%403M-17.78%370M-30.58%1.13B68.21%254M
Other non cash items 182.00%41M-71.54%-223M65.18%-180M-26,066.67%-785M53.23%-87M-134.01%-50M-402.33%-130M-10,240.00%-517M98.56%-3M-745.45%-186M
Change In working capital -11.71%1.04B332.73%238M-63.30%-1.99B53.64%-369M-184.21%-384M163.53%1.18B201.85%55M39.43%-1.22B-990.41%-796M-47.10%456M
-Change in receivables 380.34%328M-12.08%-501M-31.43%-920M-278.84%-1.5B-156.07%-240M13.97%-117M-8.23%-447M-41.13%-700M-12.78%-397M100.94%428M
-Change in inventory 372.73%90M90.27%-18M64.54%-128M2.50%-546M171.74%33M74.42%-33M4.64%-185M15.06%-361M-449.02%-560M-155.56%-46M
-Change in payables and accrued expense 40.76%-109M-294.52%-142M-1,673.08%-409M364.64%479M291.67%564M-52.07%-184M563.64%73M118.18%26M-63.06%-181M-68.83%144M
-Change in other current assets -425.00%-52M-1,266.67%-105M-149.54%-272M-48.81%-125M-2,150.00%-41M-87.40%16M-87.14%9M69.97%-109M53.07%-84M-99.27%2M
-Change in other current liabilities -47.66%783M65.95%1B-251.35%-260M211.50%1.33B-872.22%-700M111.90%1.5B28.18%605M87.33%-74M-36.51%426M-4.35%-72M
Cash from discontinued investing activities -80.12%238M0-83.41%74M59M105M-29.84%1.2B343M
Operating cash flow 16.88%6.29B36.33%4.88B-23.40%2.27B1.56%14.46B-38.04%2.55B13.92%5.38B-4.77%3.58B79.32%2.96B-5.54%14.24B5.84%4.11B
Investing cash flow
Cash flow from continuing investing activities 81.34%-374M-234.06%-3.21B-108.40%-899M252.89%6.72B22.52%-1.02B-137.75%-2B91.74%-960M14.31%10.71B-61.12%1.9B-125.11%-1.32B
Net PPE purchase and sale -52.38%-320M-0.90%-223M-50.67%-226M-8.58%-823M-18.63%-242M-4.48%-210M9.43%-221M33.04%-150M11.35%-758M-98.06%-204M
Net intangibles purchase and sale -132.48%-455M33.43%-448M-920.88%-929M122.72%262M-95.31%-375M664.92%1.4B-238.19%-673M83.02%-91M-43.41%-1.15B51.02%-192M
Net business purchase and sale 98.17%-63M-3,773.26%-3.33B-911.54%-263M-313.08%-3.57B-22.22%-11M-57,533.33%-3.45B-40.98%-86M96.90%-26M-104.22%-864M-100.04%-9M
Net investment purchase and sale 84.46%463M3,875.00%795M-95.27%519M131.82%10.85B56.89%-394M-95.64%251M100.18%20M0.07%10.97B133.78%4.68B93.88%-914M
Net other investing changes --1M----------------------------98.18%-1M--0
Cash from discontinued investing activities
Investing cash flow 83.09%-374M-204.56%-3.21B-108.46%-899M281.20%5.6B-19.97%-1.76B-142.55%-2.21B90.94%-1.05B13.41%10.62B-65.11%1.47B-132.15%-1.47B
Financing cash flow
Cash flow from continuing financing activities 91.13%-382M15.03%-3.2B42.60%-5.16B15.07%-17.56B87.90%-496M9.33%-4.31B-63.60%-3.77B5.58%-9B-26.96%-20.68B-25.08%-4.1B
Net issuance payments of debt 192.83%2.51B207.62%833M23.58%1.15B25.15%-1.94B148.41%610M-31.07%-2.7B-333.84%-774M130.94%933M56.82%-2.59B59.50%-1.26B
Net common stock issuance -75.63%-2.85B45.35%-1.62B61.92%-1.1B18.15%-8.72B53.29%-1.25B40.21%-1.63B-8.95%-2.96B-13.53%-2.89B-248.45%-10.65B-1,709.46%-2.68B
Cash dividends paid -------2.42B28.23%-5.21B3.34%-7.26B--0--------3.34%-7.26B-1.87%-7.51B--0
Proceeds from stock option exercised by employees --5M--25M----53.00%153M---5M--------69.15%159M88.68%100M--0
Net other financing activities -286.96%-43M28.57%-25M-120.75%-11M605.26%192M193.17%150M-28.13%23M-146.67%-35M140.91%53M-155.07%-38M-794.44%-161M
Cash from discontinued financing activities 2,661.34%3.29B-205.71%-111M31,481.82%3.47B129M-206M357.69%119M105M
Financing cash flow 54.09%-382M12.02%-3.2B43.88%-5.16B30.56%-14.28B84.80%-607M82.44%-832M-57.99%-3.64B3.42%-9.2B-26.43%-20.56B-22.85%-3.99B
Net cash flow
Beginning cash position -27.40%7.9B-21.09%9.47B78.17%13.39B-39.41%7.52B42.16%12.41B200.28%10.89B-13.37%12B-39.41%7.52B28.46%12.41B21.01%8.73B
Current changes in cash 228.00%5.53B-37.52%-1.53B-186.79%-3.8B218.90%5.78B161.33%828M-67.46%1.69B89.05%-1.11B194.48%4.38B-261.13%-4.86B-125.98%-1.35B
Effect of exchange rate changes 206.02%176M-3,300.00%-34M-217.76%-126M412.50%100M13.48%160M-107.50%-166M98.08%-1M360.98%107M87.97%-32M--141M
End cash Position 9.71%13.61B-27.40%7.9B-21.09%9.47B78.17%13.39B78.17%13.39B42.16%12.41B200.28%10.89B-13.37%12B-39.41%7.52B-39.41%7.52B
Free cash flow 16.87%5.49B54.85%4.15B-56.81%1.11B-2.43%11.71B-51.18%1.76B10.50%4.7B-15.57%2.68B225.06%2.57B-4.14%12B8.76%3.61B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept CAR-T Therapy
CAR-T Therapy
Intraday-1.43%
Cancer Research
Cancer Research
Intraday-2.68%